Boston Scientific (BSX-PA) Financial Statements
Price: $122.18
Market Cap: $175.45B
Avg Volume: 191.49K
Market Cap: $175.45B
Avg Volume: 191.49K
Country: US
Industry: Medical - Devices
Sector: Healthcare
Industry: Medical - Devices
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Boston Scientific.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.75B | $14.24B | $12.68B | $11.89B | $9.91B | $10.73B | $9.82B | $9.05B | $8.39B | $7.48B |
| Cost of Revenue | $5.26B | $4.34B | $4.00B | $3.76B | $3.51B | $3.18B | $2.88B | $2.66B | $2.50B | $2.24B |
| Gross Profit | $11.49B | $9.89B | $8.68B | $8.13B | $6.40B | $7.55B | $6.94B | $6.39B | $5.88B | $5.23B |
| Gross Profit Ratio | 68.61% | 69.50% | 68.44% | 68.40% | 64.59% | 70.37% | 70.65% | 70.59% | 70.15% | 70.00% |
| Research and Development Expenses | $1.61B | $1.41B | $1.32B | $1.20B | $1.14B | $1.17B | $1.11B | $997.00M | $920.00M | $876.00M |
| General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $3.57B | $3.29B | $3.10B | $2.87B |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $5.98B | $5.19B | $4.52B | $4.36B | $3.79B | $3.94B | $3.57B | $3.29B | $3.10B | $2.87B |
| Other Expenses | $1.29B | $948.00M | $803.00M | $741.00M | $789.00M | $699.00M | $156.00M | $-124.00M | $-37.00M | $-39.00M |
| Operating Expenses | $8.89B | $7.55B | $6.65B | $6.30B | $5.72B | $5.81B | $5.28B | $4.86B | $4.56B | $4.24B |
| Cost and Expenses | $14.14B | $11.90B | $10.65B | $10.06B | $9.23B | $8.99B | $8.16B | $7.52B | $7.07B | $6.49B |
| Interest Income | $107.00M | $22.00M | $10.00M | $4.00M | $3.00M | $30.00M | $3.00M | $5.00M | $5.00M | $5.00M |
| Interest Expense | $305.00M | $265.00M | $470.00M | $341.00M | $361.00M | $473.00M | $241.00M | $229.00M | $233.00M | $284.00M |
| Depreciation and Amortization | $- | $1.20B | $1.14B | $1.09B | $1.12B | $1.01B | $894.00M | $844.00M | $815.00M | $495.00M |
| EBITDA | $2.60B | $3.45B | $2.74B | $2.52B | $1.51B | $2.21B | $2.58B | $2.01B | $1.23B | $360.00M |
| EBITDA Ratio | 15.54% | 24.25% | 22.08% | 23.42% | 18.49% | 19.39% | 24.59% | 21.81% | 21.79% | 19.34% |
| Operating Income | $2.60B | $2.34B | $1.65B | $2.04B | $1.04B | $1.52B | $1.51B | $1.28B | $447.00M | $-327.00M |
| Operating Income Ratio | 15.54% | 16.45% | 13.00% | 17.19% | 10.53% | 14.14% | 15.33% | 14.20% | 5.33% | -4.37% |
| Total Other Income Expenses Net | $-321.00M | $-358.00M | $-508.00M | $-123.00M | $-1.12B | $-831.00M | $-84.00M | $-352.00M | $-270.00M | $-323.00M |
| Income Before Tax | $2.28B | $1.99B | $1.14B | $1.08B | $-138.00M | $687.00M | $1.42B | $933.00M | $177.00M | $-650.00M |
| Income Before Tax Ratio | 13.63% | 13.94% | 9.00% | 9.05% | -1.39% | 6.40% | 14.48% | 10.31% | 2.11% | -8.69% |
| Income Tax Expense | $436.00M | $393.00M | $443.00M | $36.00M | $2.00M | $-4.01B | $-249.00M | $828.00M | $-170.00M | $-411.00M |
| Net Income | $1.85B | $1.59B | $698.00M | $1.04B | $-140.00M | $4.70B | $1.67B | $104.00M | $347.00M | $-239.00M |
| Net Income Ratio | 11.06% | 11.19% | 5.50% | 8.76% | -1.41% | 43.78% | 17.01% | 1.15% | 4.14% | -3.20% |
| EPS | $1.26 | $1.08 | $0.45 | $0.69 | $-0.10 | $3.38 | $1.21 | $0.08 | $0.26 | $-0.18 |
| EPS Diluted | $1.25 | $1.07 | $0.45 | $0.69 | $-0.10 | $3.33 | $1.19 | $0.07 | $0.25 | $-0.18 |
| Weighted Average Shares Outstanding | 1.47B | 1.45B | 1.43B | 1.42B | 1.42B | 1.39B | 1.38B | 1.37B | 1.36B | 1.33B |
| Weighted Average Shares Outstanding Diluted | 1.49B | 1.46B | 1.44B | 1.43B | 1.42B | 1.41B | 1.40B | 1.39B | 1.38B | 1.34B |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $414.00M | $865.00M | $928.00M | $1.93B | $1.73B | $217.00M | $146.00M | $188.00M | $196.00M | $319.00M |
| Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $414.00M | $865.00M | $928.00M | $1.93B | $1.73B | $217.00M | $146.00M | $188.00M | $196.00M | $319.00M |
| Net Receivables | $2.56B | $2.23B | $1.97B | $1.78B | $1.53B | $1.83B | $1.61B | $1.55B | $1.47B | $1.27B |
| Inventory | $2.81B | $2.48B | $1.87B | $1.61B | $1.35B | $1.58B | $1.17B | $1.08B | $955.00M | $1.02B |
| Other Current Assets | $1.14B | $937.00M | $995.00M | $1.00B | $2.08B | $1.07B | $1.08B | $1.01B | $616.00M | $918.00M |
| Total Current Assets | $6.92B | $6.51B | $5.76B | $6.32B | $6.69B | $4.70B | $4.00B | $3.82B | $3.24B | $3.47B |
| Property Plant Equipment Net | $3.29B | $3.30B | $2.83B | $2.69B | $2.54B | $2.42B | $1.78B | $1.70B | $1.63B | $1.49B |
| Goodwill | $17.09B | $14.39B | $12.92B | $11.99B | $9.95B | $10.18B | $7.91B | $7.00B | $6.68B | $6.47B |
| Intangible Assets | $6.68B | $6.00B | $5.90B | $6.12B | $5.92B | $7.89B | $6.37B | $5.84B | $5.88B | $6.19B |
| Goodwill and Intangible Assets | $23.77B | $20.39B | $18.82B | $18.11B | $15.87B | $18.06B | $14.28B | $12.84B | $12.56B | $12.67B |
| Long Term Investments | $- | $413.00M | $407.00M | $412.00M | $918.00M | $458.00M | $-328.00M | $-191.00M | $-75.00M | $-496.00M |
| Tax Assets | $3.65B | $3.84B | $3.94B | $4.14B | $4.21B | $4.20B | $328.00M | $191.00M | $75.00M | $496.00M |
| Other Non-Current Assets | $1.75B | $680.00M | $707.00M | $563.00M | $545.00M | $735.00M | $932.00M | $688.00M | $666.00M | $505.00M |
| Total Non-Current Assets | $32.48B | $28.62B | $26.71B | $25.91B | $24.08B | $25.87B | $17.00B | $15.22B | $14.86B | $14.66B |
| Other Assets | $- | $- | $- | $2.00M | $3.00M | $- | $-2.00M | $- | $- | $- |
| Total Assets | $39.40B | $35.14B | $32.47B | $32.23B | $30.78B | $30.57B | $21.00B | $19.04B | $18.10B | $18.13B |
| Account Payables | $960.00M | $942.00M | $862.00M | $794.00M | $513.00M | $542.00M | $349.00M | $530.00M | $447.00M | $209.00M |
| Short Term Debt | $1.78B | $531.00M | $20.00M | $261.00M | $13.00M | $1.42B | $2.25B | $1.80B | $64.00M | $3.00M |
| Tax Payables | $307.00M | $220.00M | $232.00M | $209.00M | $158.00M | $265.00M | $161.00M | $66.00M | $- | $- |
| Deferred Revenue | $- | $266.00M | $220.00M | $208.00M | $138.00M | $144.00M | $328.00M | $191.00M | $75.00M | $496.00M |
| Other Current Liabilities | $3.35B | $2.97B | $2.47B | $2.80B | $2.86B | $2.50B | $2.50B | $3.26B | $3.08B | $2.22B |
| Total Current Liabilities | $6.40B | $4.93B | $3.80B | $4.27B | $3.68B | $4.87B | $5.26B | $5.65B | $3.59B | $2.43B |
| Long Term Debt | $8.97B | $8.96B | $9.26B | $9.19B | $9.53B | $8.87B | $4.80B | $3.82B | $5.42B | $5.67B |
| Deferred Revenue Non-Current | $- | $311.00M | $289.00M | $276.00M | $257.00M | $1.20B | $1.19B | $1.88B | $- | $- |
| Deferred Tax Liabilities Non-Current | $155.00M | $134.00M | $144.00M | $310.00M | $330.00M | $595.00M | $328.00M | $191.00M | $18.00M | $735.00M |
| Other Non-Current Liabilities | $1.87B | $1.27B | $1.40B | $1.55B | $1.66B | $2.36B | $1.88B | $2.37B | $2.34B | $2.97B |
| Total Non-Current Liabilities | $10.99B | $10.67B | $11.09B | $11.33B | $11.77B | $11.82B | $7.01B | $6.38B | $7.78B | $9.38B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $17.39B | $15.61B | $14.90B | $15.61B | $15.45B | $16.69B | $12.27B | $12.03B | $11.36B | $11.81B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $17.00M | $17.00M | $17.00M | $17.00M | $17.00M | $16.00M | $16.00M | $16.00M | $19.00M | $16.00M |
| Retained Earnings | $2.67B | $819.00M | $-750.00M | $-1.39B | $-2.38B | $-2.25B | $-6.95B | $-8.39B | $-8.58B | $-8.93B |
| Accumulated Other Comprehensive Income Loss | $275.00M | $49.00M | $269.00M | $263.00M | $207.00M | $270.00M | $33.00M | $-59.00M | $1.00M | $88.00M |
| Other Total Stockholders Equity | $18.80B | $18.40B | $18.04B | $17.73B | $17.48B | $15.84B | $15.66B | $15.45B | $15.30B | $15.14B |
| Total Stockholders Equity | $21.77B | $19.28B | $17.57B | $16.62B | $15.33B | $13.88B | $8.72B | $7.01B | $6.73B | $6.32B |
| Total Equity | $22.00B | $19.53B | $17.57B | $16.62B | $15.33B | $13.88B | $8.72B | $7.01B | $6.73B | $6.32B |
| Total Liabilities and Stockholders Equity | $39.40B | $34.89B | $32.47B | $32.23B | $30.78B | $30.57B | $21.00B | $19.04B | $18.10B | $18.13B |
| Minority Interest | $233.00M | $248.00M | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $39.40B | $34.89B | $32.47B | $32.23B | $30.78B | $30.57B | $21.00B | $19.04B | $18.10B | $18.13B |
| Total Investments | $555.00M | $413.00M | $407.00M | $412.00M | $918.00M | $458.00M | $-328.00M | $-191.00M | $-75.00M | $-496.00M |
| Total Debt | $10.75B | $9.49B | $9.28B | $9.45B | $9.54B | $10.28B | $7.03B | $5.58B | $5.48B | $5.68B |
| Net Debt | $10.33B | $8.63B | $8.35B | $7.53B | $7.80B | $10.06B | $6.88B | $5.39B | $5.29B | $5.36B |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $1.85B | $1.59B | $698.00M | $1.04B | $-82.00M | $4.70B | $1.67B | $104.00M | $347.00M | $-239.00M |
| Depreciation and Amortization | $1.27B | $1.20B | $1.14B | $1.09B | $1.12B | $1.01B | $894.00M | $844.00M | $815.00M | $769.00M |
| Deferred Income Tax | $- | $-1.00M | $-63.00M | $-124.00M | $-82.00M | $-4.30B | $-87.00M | $245.00M | $-305.00M | $-532.00M |
| Stock Based Compensation | $266.00M | $233.00M | $220.00M | $194.00M | $170.00M | $157.00M | $140.00M | $127.00M | $116.00M | $107.00M |
| Change in Working Capital | $- | $-770.00M | $-1.00B | $-351.00M | $42.00M | $-282.00M | $-2.16B | $66.00M | $-4.00M | $280.00M |
| Accounts Receivables | $-351.00M | $-238.00M | $-220.00M | $-279.00M | $335.00M | $-130.00M | $-110.00M | $-30.00M | $-216.00M | $-17.00M |
| Inventory | $-228.00M | $-660.00M | $-321.00M | $-346.00M | $-65.00M | $-290.00M | $-83.00M | $-107.00M | $40.00M | $3.00M |
| Accounts Payables | $243.00M | $118.00M | $-255.00M | $408.00M | $88.00M | $111.00M | $-710.00M | $195.00M | $553.00M | $-20.00M |
| Other Working Capital | $- | $10.00M | $-209.00M | $-134.00M | $-316.00M | $27.00M | $-1.26B | $8.00M | $-381.00M | $314.00M |
| Other Non Cash Items | $54.00M | $253.00M | $540.00M | $17.00M | $337.00M | $551.00M | $-148.00M | $40.00M | $3.00M | $215.00M |
| Net Cash Provided by Operating Activities | $3.44B | $2.50B | $1.53B | $1.87B | $1.51B | $1.84B | $310.00M | $1.43B | $972.00M | $600.00M |
| Investments in Property Plant and Equipment | $-790.00M | $-711.00M | $-612.00M | $-554.00M | $-376.00M | $-461.00M | $-316.00M | $-319.00M | $-376.00M | $-247.00M |
| Acquisitions Net | $-4.64B | $-1.81B | $-1.54B | $-1.43B | $12.00M | $-4.29B | $-1.45B | $-560.00M | $-408.00M | $-1.73B |
| Purchases of Investments | $- | $- | $-24.00M | $96.00M | $-146.00M | $-348.00M | $-172.00M | $-131.00M | $-132.00M | $-266.00M |
| Sales Maturities of Investments | $- | $- | $56.00M | $294.00M | $12.00M | $59.00M | $14.00M | $131.00M | $- | $61.00M |
| Other Investing Activities | $-257.00M | $-52.00M | $106.00M | $-1.00M | $87.00M | $1.00M | $1.00M | $-131.00M | $29.00M | $-205.00M |
| Net Cash Used for Investing Activities | $-5.69B | $-2.57B | $-2.01B | $-1.60B | $-411.00M | $-5.04B | $-1.92B | $-1.01B | $-887.00M | $-2.19B |
| Debt Repayment | $1.83B | $-4.00M | $-165.00M | $- | $-999.00M | $2.79B | $1.41B | $123.00M | $-190.00M | $1.39B |
| Common Stock Issued | $- | $182.00M | $- | $110.00M | $975.00M | $123.00M | $101.00M | $85.00M | $111.00M | $114.00M |
| Common Stock Repurchased | $- | $182.00M | $136.00M | $110.00M | $-535.00M | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $-28.00M | $-55.00M | $-55.00M | $-28.00M | $- | $- | $- | $- | $- |
| Other Financing Activities | $-13.00M | $37.00M | $-464.00M | $-40.00M | $880.00M | $179.00M | $27.00M | $-98.00M | $-127.00M | $-177.00M |
| Net Cash Used Provided by Financing Activities | $1.81B | $5.00M | $-548.00M | $-95.00M | $293.00M | $2.97B | $1.43B | $110.00M | $-206.00M | $1.32B |
| Effect of Forex Changes on Cash | $-11.00M | $-4.00M | $-9.00M | $-6.00M | $-2.00M | $10.00M | $-8.00M | $4.00M | $-2.00M | $-4.00M |
| Net Change in Cash | $-449.00M | $-71.00M | $-1.04B | $173.00M | $1.39B | $-222.00M | $-188.00M | $530.00M | $-123.00M | $-268.00M |
| Cash at End of Period | $606.00M | $1.05B | $1.13B | $2.17B | $2.00B | $607.00M | $829.00M | $1.02B | $196.00M | $319.00M |
| Cash at Beginning of Period | $1.05B | $1.13B | $2.17B | $2.00B | $607.00M | $829.00M | $1.02B | $487.00M | $319.00M | $587.00M |
| Operating Cash Flow | $3.44B | $2.50B | $1.53B | $1.87B | $1.51B | $1.84B | $310.00M | $1.43B | $972.00M | $600.00M |
| Capital Expenditure | $-790.00M | $-800.00M | $-612.00M | $-554.00M | $-376.00M | $-461.00M | $-316.00M | $-319.00M | $-376.00M | $-247.00M |
| Free Cash Flow | $2.65B | $1.70B | $914.00M | $1.32B | $1.13B | $1.38B | $-6.00M | $1.11B | $596.00M | $353.00M |